Literature DB >> 7634044

Primary cemented total hip arthroplasty: five to twelve year clinical and radiographic follow-up.

I Hirose1, W N Capello, J R Feinberg, R M Shirer.   

Abstract

A retrospective clinical and roentgenographic study was completed on 131 primary cemented total hip arthroplasties with a minimum of five years follow-up (mean, seven years; range, five to twelve years). Second generation cement technique including plugging of the medullary canal, cement gun filling, and pressurization of the canal was used. Acetabular cement was also pressurized. The total mechanical failure rate of the acetabular components was 18.4% compared to that of the femoral components which was 3.1%. There was a significantly higher incidence of acetabular component failure in rheumatoid arthritis patients (38.9%) compared to a preoperative diagnosis of primary osteoarthritis (14.1%) (p = 0.013). Yet there were no rheumatoid arthritis patients in the femoral component revision group. There were no differences in revision rates for metal-backed versus nonmetal-backed cups (p = 0.113). The average thickness of the proximal medial cement mantle was 2.8 millimeters in the loosening group and 5.4 millimeters in the nonloosening group (p = 0.333). All failures occurred in those patients whose proximal medial cement mantle was less than five millimeters. The authors strongly endorse the use of hybrid total hip arthroplasty and emphasize the need for meticulous surgical technique especially in obtaining a cement mantle of sufficient thickness in the proximal medial aspect of the femur.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634044      PMCID: PMC2329078     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  18 in total

1.  The effect of high pressure insertion and antibiotic inclusions upon the mechanical properties of polymethylmethacrylate.

Authors:  A M Weinstein; D N Bingham; B W Sauer; E M Lunceford
Journal:  Clin Orthop Relat Res       Date:  1976 Nov-Dec       Impact factor: 4.176

2.  Radiographic analysis of a low-modulus titanium-alloy femoral total hip component. Two to six-year follow-up.

Authors:  A Sarmiento; T A Gruen
Journal:  J Bone Joint Surg Am       Date:  1985-01       Impact factor: 5.284

3.  The cement mantle in total hip arthroplasty. Analysis of long-term radiographic results.

Authors:  E Ebramzadeh; A Sarmiento; H A McKellop; A Llinas; W Gogan
Journal:  J Bone Joint Surg Am       Date:  1994-01       Impact factor: 5.284

4.  The femoral cement compactor. An improvement in cementing technique in total hip replacement.

Authors:  I Oh; R B Bourne; W H Harris
Journal:  J Bone Joint Surg Am       Date:  1983-12       Impact factor: 5.284

5.  Improved fixation of the femoral component after total hip replacement using a methacrylate intramedullary plug.

Authors:  I Oh; C E Carlson; W W Tomford; W H Harris
Journal:  J Bone Joint Surg Am       Date:  1978-07       Impact factor: 5.284

6.  Stress distributions in the acetabular region--I. Before and after total joint replacement.

Authors:  R Vasu; D R Carter; W H Harris
Journal:  J Biomech       Date:  1982       Impact factor: 2.712

7.  Stress distributions in the acetabular region--II. Effects of cement thickness and metal backing of the total hip acetabular component.

Authors:  D R Carter; R Vasu; W H Harris
Journal:  J Biomech       Date:  1982       Impact factor: 2.712

8.  "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening.

Authors:  T A Gruen; G M McNeice; H C Amstutz
Journal:  Clin Orthop Relat Res       Date:  1979-06       Impact factor: 4.176

9.  Femoral component loosening using contemporary techniques of femoral cement fixation.

Authors:  W H Harris; J C McCarthy; D A O'Neill
Journal:  J Bone Joint Surg Am       Date:  1982-09       Impact factor: 5.284

10.  Advances in total hip arthroplasty. The metal-backed acetabular component.

Authors:  W H Harris
Journal:  Clin Orthop Relat Res       Date:  1984-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.